OBJECTIVE: To compare the Quality of Life (QOL) of multiple sclerosis (MS) patients with and without lifetime major depression. METHOD: Data on 136 MS subjects sampled from the University of Calgary MS Clinic were collected. The WHO's Composite International Diagnostic Interview (CIDI) was used to diagnose lifetime major depression. The MSQOL-54 was administered to evaluate QOL of the subjects. RESULTS: Thirty one (22.8 percent) of the 136 MS subjects had lifetime major depression, However, only 6 of these had a current episode at the time of data collection. MS patients with lifetime major depression had significantly lower MSQOL-54 scores in the QOL domains of Energy, Mental Health, Cognitive Function, General Quality of Life, Sexual Function, and Role Limitation-Emotional than the MS patients without lifetime major depression. CONCLUSIONS: Lifetime major depression may have a substantial impact on the QOL of people with MS. Alternatively, MS patients with poor QOL may be at greater risk of major depression.
OBJECTIVE: To compare the Quality of Life (QOL) of multiple sclerosis (MS) patients with and without lifetime major depression. METHOD: Data on 136 MS subjects sampled from the University of Calgary MS Clinic were collected. The WHO's Composite International Diagnostic Interview (CIDI) was used to diagnose lifetime major depression. The MSQOL-54 was administered to evaluate QOL of the subjects. RESULTS: Thirty one (22.8 percent) of the 136 MS subjects had lifetime major depression, However, only 6 of these had a current episode at the time of data collection. MSpatients with lifetime major depression had significantly lower MSQOL-54 scores in the QOL domains of Energy, Mental Health, Cognitive Function, General Quality of Life, Sexual Function, and Role Limitation-Emotional than the MSpatients without lifetime major depression. CONCLUSIONS: Lifetime major depression may have a substantial impact on the QOL of people with MS. Alternatively, MSpatients with poor QOL may be at greater risk of major depression.
Authors: João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier Journal: Ther Adv Neurol Disord Date: 2011-05 Impact factor: 6.570
Authors: Sarah L Minden; Anthony Feinstein; Rosalind C Kalb; Deborah Miller; David C Mohr; Scott B Patten; Christopher Bever; Randolph B Schiffer; Gary S Gronseth; Pushpa Narayanaswami Journal: Neurology Date: 2013-12-27 Impact factor: 9.910
Authors: Ruth Ann Marrie; Scott B Patten; Lindsay I Berrigan; Helen Tremlett; Christina Wolfson; Sharon Warren; Stella Leung; Kirsten M Fiest; Kyla A McKay; John D Fisk Journal: Int J MS Care Date: 2018 Mar-Apr